Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses

Neurobiology of Disease

Volumn 62, Issue , 2014, Pages 456-468

  Herz, Josephine ^a   Hagen, Sabine I ^a   Bergmüller, Eileen ^a   Sabellek, Pascal ^a   Göthert, Joachim R ^a   Buer, Jan ^a   Hansen, Wiebke ^a   Hermann, Dirk M ^a   Doeppner, Thorsten R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cerebral ischemia; Hypercholesterolemia; Neuroinflammation

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CELL ACTIVATION; CELL COUNT; CELL MIGRATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COMORBIDITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; EXPERIMENTAL MOUSE; GRANULOCYTE; HYPERCHOLESTEROLEMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTOSIS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TISSUE DISTRIBUTION; UPREGULATION; WILD TYPE;

CEREBRAL ISCHEMIA; HYPERCHOLESTEROLEMIA; NEUROINFLAMMATION;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL CORTEX; CHEMOKINES; CHOLESTEROL; ENDOTHELIAL CELLS; GRANULOCYTES; HYPERCHOLESTEROLEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; LEUKOCYTOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS;

EID: 84888035289     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.10.022     Document Type: Article

References (41)

1. Ayata C., Shin H.K., Dileköz E., Atochin D.N., Kashiwagi S., Eikermann-Haerter K., Huang P.L. Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect. J. Cereb. Blood Flow Metab. 2013, (Epub ahead of print). 10.1038/jcbfm.2013.38.
2. Bacigaluppi M., Pluchino S., Peruzzotti-Jametti L., Kilic E., Kilic U., Salani G., Brambilla E., West M.J., Comi G., Martino G., Hermann D.M. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009, 132:2239-2251.
3. Beray-Berthat V., Palmier B., Plotkine M., Margaill I. Neutrophils do not contribute to infarction, oxidative stress, and no synthase activity in severe brain ischemia. Exp. Neurol. 2003, 182:446-454.
4. Callahan A., Amarenco P., Goldstein L.B., Sillesen H., Messig M., Samsa G.P., Altfullah I., Ledbetter L.Y., MacLeod M.J., Scott R., Hennerici M., Zivin J.A., Welch K.M., SPARCL Investigators Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch. Neurol. 2011, 68:1245-1251.
5. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
6. Dirnagl U., Klehmet J., Braun J.S., Harms H., Meisel C., Ziemssen T., Prass K., Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007, 38:770-773.
7. Drake C., Boutin H., Jones M.S., Denes A., McColl B.W., Selvarajah J.R., Hulme S., Georgiou R.F., Hinz R., Gerhard A., Vail A., Prenant C., Julyan P., Maroy R., Brown G., Smigova A., Herholz K., Kassiou M., Crossman D., Francis S., Proctor S.D., Russell J.C., Hopkins S.J., Tyrrell P.J., Rothwell N.J., Allan S.M. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun. 2011, 25:1113-1122.
8. Drechsler M., Megens R.T., van Zandvoort M., Weber C., Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010, 122:1837-1845.
9. ElAli A., Doeppner T.R., Zechariah A., Hermann D.M. Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and RhoA overactivation. Stroke 2011, 42:3238-3244.
10. Emerich D.F., Dean R.L., Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp. Neurol. 2002, 173:168-181.
11. Emsley H.C., Smith C.J., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., Hallenbeck J.M., del Zoppo G.J., Rothwell N.J., Tyrrell P.J., Hopkins S.J. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J. Neuroimmunol. 2003, 139:93-101.
12. Endres M., Engelhardt B., Koistinaho J., Lindvall O., Meairs S., Mohr J.P., Planas A., Rothwell N., Schwanninger M., Schwab M.E., Vivien D., Wieloch T., Drinagl U. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc. Dis. 2008, 25:268-278.
13. Enlimomab Acute Stroke Trial Investigators Use of anti-ICAM-1 therapy in ischemic stroke. Results of the Enlimomab Acute Stroke Trial. Neurology 2001, 57:1428-1434.
14. Fisher M., Feuerstein G., Howells D.W., Hurn P.D., Kent T.A., Savitz S.I., Lo E.H., for the STAIR Group Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250.
15. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.U., Siler D.A., Arumugam T.V., Orthey E., Gerloff C., Tolosa E., Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
16. Giugliano G., Brevetti G., Lanero S., Schiano V., Laurenzano E., Chiariello M. Leukocyte count in peripheral arterial disease: a simple, reliable, inexpensive approach to cardiovascular risk prediction. Atherosclerosis 2010, 210:288-293.
17. Gliem M., Mausberg A.K., Lee J.I., Simiantonakis I., van Rooijen N., Hartung H.P., Jander S. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann. Neurol. 2012, 71:743-752.
18. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F., American Heart Association, National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
19. Harms H., Prass K., Meisel C., Klehmet J., Rogge W., Drenckhahn C., Göhler J., Bereswill S., Göbel U., Wernecke K.D., Wolf T., Arnold G., Halle E., Volk H.D., Dirnagl U., Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. Plos One 2008, 10.1371/journal.pone.0002158.
20. Herz J., Reitmeir R., Hagen S.I., Reinboth B.S., Guo Z., Zechariah A., ElAli A., Doeppner T.R., Bacigaluppi M., Pluchino S., Kilic U., Kilic E., Hermann D.M. Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity afer focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol. Dis. 2012, 45:1077-7085.
21. Ho C.S., López J.A., Vuckovic S., Pyke C.M., Hockey R.L., Hart D.N. Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts. Blood 2001, 98(1):140-145.
22. Iadecola and Anrather The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
23. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
24. Jin F., Hagemann N., Brockmeier U., Schäfer S.T., Zechariah A., Hermann D.M. LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network trafficking. Angiogenesis 2013, 10.1093/cvr/cvt209.
25. Kim E., Tolhurst A.T., Qin L.Y., Chen X.Y., Febbraio M., Cho S. CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury. J. Neurosci. 2008, 28:4661-4670.
26. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97.
27. Langdon K.D., Maclellan C.L., Corbett D. Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat. J. Cereb. Blood Flow Metab. 2010, 30:1450-1459.
28. Macrez R., Ali C., Toutirais O., LeMauff B., Defer G., Dirnagl U., Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011, 10:471-480.
29. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammation alters the kinetic of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 2008, 28:9451-9462.
30. McColl B.W., Allan S.M., Rothwell N.J. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009, 158:1049-1061.
31. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 2005, 6:775-786.
32. Murphy A.J., Akhtari M., Tolani S., Pagler T., Bijl N., Kuo C.L., Wang M., Sanson M., Abramowicz S., Welch C., Bochem A.E., Kuivenhoven J.A., Yvan-Charvet L., Tall A.R. ApoE regulates hematopoietic stem cell proliferation, monocytosis and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Invest. 2011, 121:4138-4149.
33. Offner H., Subramanian S., Parker S.M., Afentoulis M.E., Vandenbark A.A., Hurd P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 2006, 26:654-665.
34. Prass K., Meisel C., Höflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003, 198:725-736.
35. Röther J., Alberts M.J., Touzé E., Mas J.L., Hill M.D., Michel P., Bhatt D.L., Aichner F.T., Goto S., Matsumoto M., Ohman E.M., Okada Y., Uchiyama S., D'Agostino R., Hirsch A.T., Wilson P.W., Steg P.G., REACH Registry Investigators Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc. Dis. 2008, 25:366-374.
36. Smith C.J., Emsley H.C., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., del Zoppo G.J., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., Tyrell P.J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004, 4:2.
37. Smith E., Prasad K.M., Burcher M., Dobrian A., Kolls J.K., Ley K., Galkina E. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755.
38. Tuttolomondo A., Di Raimondo D., Di Sciacca R., Pecoraro R., Arnao V., Buttà C., Licata G., Pinto A. Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. Atherosclerosis 2012, 225:216-219.
39. Vijayalekshmi K.S., Leelamma S. Mechanisms of hypercholesterolemia produced by some antibiotics. Indian J. Clin. Biochem. 1991, 6:31-38.
40. Wu H., Gower R.M., Wang H., Perrard X.Y., Ma R., Bullard D.C., Burns A.R., Paul A., Smith C.W., Simon S.I., Ballantyne C.M. Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009, 119:2708-2717.
41. Zechariah A., Jin F., Doeppner T.R., Elali A., Helfrich I., Mies G., Hermnann D.M. Hyperlipidemia attenuates vascular endothelial growth factor induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1561-1567.